Search
BRD-810
go.drugbank.com/drugs/DB23607ExperimentalBRD-810 is an experimental small molecule being investigated as a potential anti-cancer medication. It is an inhibitor of the protein myeloid cell leukemia 1 (MCL1). [A274263]
Butyrylthiocholine
go.drugbank.com/drugs/DB04250ExperimentalIt is used as a reagent in the determination of butyrylcholinesterase activity. [PubChem]
TAS-102
go.drugbank.com/drugs/DB08937InvestigationalTAS-102 (Taiho Pharma USA, Inc.) is an anti-cancer drug under development and in stage 3 clinical trials for the treatment of colorectal cancer.
Telratolimod
go.drugbank.com/drugs/DB19590InvestigationalTelratolimod has a monoisotopic molecular weight of 593.47 Da.
Icenticaftor
go.drugbank.com/drugs/DB21466InvestigationalIcenticaftor has a monoisotopic molecular weight of 361.09 Da.
Rezivertinib
go.drugbank.com/drugs/DB21471InvestigationalRezivertinib has a monoisotopic molecular weight of 486.24 Da.
Tuxobertinib
go.drugbank.com/drugs/DB21508InvestigationalTuxobertinib has a monoisotopic molecular weight of 560.19 Da.
Linvencorvir
go.drugbank.com/drugs/DB21544InvestigationalLinvencorvir has a monoisotopic molecular weight of 598.24 Da.
Fipravirimat
go.drugbank.com/drugs/DB21578InvestigationalFipravirimat has a monoisotopic molecular weight of 726.48 Da.
Relutrigine
go.drugbank.com/drugs/DB21614InvestigationalRelutrigine has a monoisotopic molecular weight of 407.08 Da.